Europe — EMA
Lamisil Once (Terbinafine)
GNH USA supplies Lamisil Once (Terbinafine), a allylamine antifungal for athlete’s foot, ringworm and jock itch. Request a quote for supply via our network.
Request sourcing
What is Terbinafine?
Terbinafine, the active ingredient in Lamisil Once, is an allylamine antifungal presented as a topical formulation for skin application. It treats dermatophyte infections such as athlete’s foot, ringworm and jock itch in adults and children.
GNH USA supplies Lamisil Once as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Terbinafine used for?
Lamisil Once is an allylamine antifungal used to treat common dermatophyte skin infections.
- Tinea pedis: alleviates itching, scaling and redness caused by athlete’s foot. - Tinea corporis: clears ring-shaped lesions on the body. - Tinea cruris: resolves itching and erythema in the groin area.
What are the side effects of Terbinafine?
Topical terbinafine may cause local and systemic adverse reactions.
Common Side Effects: - Burning sensation at the application site - Itching - Redness - Scaling - Dryness - Mild irritation
Serious or Rare Side Effects: - Severe allergic reaction (e.g., angioedema, anaphylaxis) - Contact dermatitis - Systemic hepatotoxicity (rare with extensive use) - Stevens‑Johnson syndrome (very rare)
What precautions apply to Terbinafine?
Before using Lamisil Once, consider the following safety measures.
- Confirm diagnosis: ensure the infection is caused by dermatophytes before use. - Avoid on broken skin: do not apply to open wounds or inflamed areas. - Concurrent topical antifungals: do not combine with other antifungal creams unless directed. - Pregnancy and lactation: consult a healthcare professional before use. - Monitor for systemic symptoms: report signs of liver dysfunction or severe skin reactions. - Store at room temperature: keep in original packaging, protect from moisture and heat.
What does Terbinafine interact with?
Terbinafine may interact with other medicines; some combinations require avoidance while others need monitoring.
Major Interactions (Avoid): - Oral terbinafine: concurrent systemic use may increase risk of hepatotoxicity. - CYP2D6 inhibitors: may affect systemic absorption of terbinafine.
Moderate Interactions (Monitor Closely): - Alcohol: excessive intake may heighten liver risk if systemic absorption occurs. - Other topical irritants: may increase local skin irritation. - Phototherapy: may enhance skin sensitivity.
